"Polypharmacy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The use of multiple drugs administered to the same patient, most commonly seen in elderly patients. It includes also the administration of excessive medication. Since in the United States most drugs are dispensed as single-agent formulations, polypharmacy, though using many drugs administered to the same patient, must be differentiated from DRUG COMBINATIONS, single preparations containing two or more drugs as a fixed dose, and from DRUG THERAPY, COMBINATION, two or more drugs administered separately for a combined effect. (From Segen, Dictionary of Modern Medicine, 1992)
Descriptor ID |
D019338
|
MeSH Number(s) |
E02.319.698
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Polypharmacy".
Below are MeSH descriptors whose meaning is more specific than "Polypharmacy".
This graph shows the total number of publications written about "Polypharmacy" by people in this website by year, and whether "Polypharmacy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 2 | 1 | 3 |
2007 | 3 | 0 | 3 |
2011 | 1 | 1 | 2 |
2015 | 1 | 1 | 2 |
2016 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2019 | 2 | 2 | 4 |
2020 | 2 | 0 | 2 |
2021 | 2 | 1 | 3 |
2022 | 2 | 1 | 3 |
2023 | 0 | 1 | 1 |
2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polypharmacy" by people in Profiles.
-
Medication burden and anticholinergic use are associated with overt HE in individuals with cirrhosis. Hepatol Commun. 2024 08 01; 8(8).
-
An innovative approach to aligning healthcare with what matters most to patients: A hybrid type 1 trial protocol of patient priorities care for older adults with multiple chronic conditions. Contemp Clin Trials. 2024 Aug; 143:107613.
-
Deprescribing statins, considerations for informed decision making. J Am Geriatr Soc. 2023 08; 71(8):2685-2689.
-
Polypharmacy and medical intensive care unit (MICU) admission and 10-year all-cause mortality risk among hospitalized patients with and without HIV. PLoS One. 2022; 17(10):e0276769.
-
Predictive Risk Model for Serious Falls Among Older Persons Living With HIV. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):168-174.
-
Evaluation of the key geriatric assessment constructs in primary brain tumor population - a descriptive study. J Geriatr Oncol. 2022 11; 13(8):1194-1202.
-
Healthcare Expenditure Associated With Polypharmacy in Older Adults With Cardiovascular Diseases. Am J Cardiol. 2022 04 15; 169:156-158.
-
Preventing Home Medication Administration Errors. Pediatrics. 2021 12 01; 148(6).
-
Polypharmacy among COVID-19 patients: A systematic review. J Am Pharm Assoc (2003). 2021 Sep-Oct; 61(5):e14-e25.
-
Ground-glass hepatocellular inclusions are associated with polypharmacy. Ann Diagn Pathol. 2021 Jun; 52:151740.